Mechanistically, prolonged low levels of IFN-β signalling cause the activation of an unphosphorylated ISGF3 (U-ISGF3) complex, which promotes the expression of a subset of interferon-stimulated genes with pro-tumour functions [127–129]. This evidence concerns the gene IFNB1 and neoplasm.